By Deb Hickey In last month’s BOB Tales, the growing role of PSMA PET/CT scans was highlighted as a breakthrough tool for spotting prostate cancers that MRI-guided biopsies can miss. Now, high-resolution micro-ultrasound (microUS) is emerging as another valuable option in prostate cancer diagnosis. While MRI remains…
Participating in a cancer research study is a deeply personal decision—one that requires courage, commitment, and trust. For patients with prostate cancer, that decision can shape the future of care for generations to come. The COMPPARE study (A Prospective COMparative Study of Outcomes with Proton and Photon RAdiation in Prostate…
With just seven short months to go, we’re closing in on a major milestone: the Primary Completion Date (PCD) for the initial COMPPARE project on February 15, 2026. When you volunteered for COMPPARE, you might have heard about something its PCD. But what does that mean for you, really?…
By Deb Hickey A new study of U.S. counties found that higher rates of prostate-specific antigen (PSA) screening are linked to lower incidences of advanced or metastatic prostate cancer and reduced prostate cancer mortality rates in subsequent years. USPSTF Recommendation Led to Disastrous Results In 2012, the…
COMPPARE Newsroom Prostate cancer research news…
By Bob Marckini Last month, a gentleman told us, sadly, that his father had died from prostate cancer. He then admitted he’d met with his primary care doctor only sporadically over the years and, despite this, didn’t even have regular PSA tests or DREs. Further, he skipped doctors’ visits completely…
If you are a man between the ages of 55 and 69, September is a good time to schedule a prostate screening, one that includes both a PSA blood test and prostate examination. Consider the numbers: Prostate cancer is the most common genitourinary cancer treated by a urologist and the…
Hampton, Virginia is one of the nation’s most diverse areas of the country, and with diversity comes more opportunity to understand and address health disparities. The Hampton Roads Prostate Health Forum (HRPHF) combines the area’s diversity with its focus on addressing health disparities. The organization’s mission is to raise…
If you are a man between the ages of 55 and 69, September is a good time to schedule a prostate screening, one that includes both a PSA blood test and prostate examination. Consider the numbers: Prostate cancer is the most common genitourinary cancer treated by a urologist. Approximately one…
